- Home
- TSE vs HLVX Comparison
TSE vs HLVX Comparison
Compare TSE & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSE
- HLVX
- Stock Information
- Founded
- TSE 2010
- HLVX 2020
- Country
- TSE United States
- HLVX United States
- Employees
- TSE N/A
- HLVX N/A
- Industry
- TSE Major Chemicals
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- TSE Industrials
- HLVX Health Care
- Exchange
- TSE Nasdaq
- HLVX Nasdaq
- Market Cap
- TSE 95.2M
- HLVX 104.3M
- IPO Year
- TSE 2014
- HLVX 2022
- Fundamental
- Price
- TSE $2.51
- HLVX $2.08
- Analyst Decision
- TSE
- HLVX Hold
- Analyst Count
- TSE 0
- HLVX 1
- Target Price
- TSE N/A
- HLVX $2.00
- AVG Volume (30 Days)
- TSE 382.6K
- HLVX 829.7K
- Earning Date
- TSE 08-06-2025
- HLVX 08-06-2025
- Dividend Yield
- TSE 1.59%
- HLVX N/A
- EPS Growth
- TSE N/A
- HLVX N/A
- EPS
- TSE N/A
- HLVX N/A
- Revenue
- TSE $3,258,300,000.00
- HLVX N/A
- Revenue This Year
- TSE N/A
- HLVX N/A
- Revenue Next Year
- TSE $4.39
- HLVX N/A
- P/E Ratio
- TSE N/A
- HLVX N/A
- Revenue Growth
- TSE N/A
- HLVX N/A
- 52 Week Low
- TSE $1.90
- HLVX $1.34
- 52 Week High
- TSE $7.05
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- TSE 45.53
- HLVX 52.92
- Support Level
- TSE $1.90
- HLVX $2.07
- Resistance Level
- TSE $2.54
- HLVX $2.10
- Average True Range (ATR)
- TSE 0.17
- HLVX 0.04
- MACD
- TSE 0.01
- HLVX -0.01
- Stochastic Oscillator
- TSE 59.86
- HLVX 50.00
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.